Statistics for Rhythm Pharmaceuticals (id:6463 RYTM)

Valuation metrics

Market cap

3.67B

Enterprise value

3.65B

Trailing P/E (ttm)

-18.73

Forward P/E

-22.39

PEG ratio

-22.39

Price/Sales (ttm)

32.64

Price/Book (mrq)

326.61

Enterprise Value/Revenue

32.42

Enterprise Value/EBITDA

-13.82

Overview

Shares outstanding

61.46M

Float

45.16M

Shares short

8.36M

% Held by insiders

0.01%

% Held by institutions

1.18%

Average volume (10 days)

1.03M

Average volume (90 days)

Price summary

52-Week low

31.52

52-Week high

68.58

52-Week change

42.21%

Beta

2.09

50-Day moving average

52.00

200-Day moving average

45.37

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

-230.11%

Operating margin

-131.98%

Operational effectiveness

Return on assets

-46.24%

Return on equity

-147.90%

Income statement

Revenue (ttm)

1.86

Revenue per share (ttm)

1.86

Quarterly revenue growth (yoy)

Gross profit (ttm)

68.13M

EBITDA

-263,916,000.00

Net income to common (ttm)

-261,574,000.00

Diluted EPS (ttm)

-4.32

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

298.39M

Total cash per share (mrq)

4.86

Total debt (mrq)

113.27M

Total Debt/Equity (mrq)

74.18

Current ratio (mrq)

348.70%

Book value per share (mrq)

0.18

Cash flow

Cash flow statement

-124,417,000.00

Levered free cash flow (LFCF)

-143,164,880.00